REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Enzychem Lifesciences Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Enzychem Lifesciences Corporation Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the Manufacture of Medicinal Chemicals, Antibiotics and Biological Products. The Company was founded on July 20, 1999 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on September 25, 2013. On 21 February 2018, delisted from KOREA NEW EXCHANGE(KONEX).

Headquarters
193 Moonji-Dong, Yooseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Enzychem Lifesciences Corporation report to view the information.

Website: http://enzychem.com

Basic Information
Total Employees:
Purchase the Enzychem Lifesciences Corporation report to view the information.
Outstanding Shares:
Purchase the Enzychem Lifesciences Corporation report to view the information.
Registered Capital:
Purchase the Enzychem Lifesciences Corporation report to view the information.
Financial Auditors:
Purchase the Enzychem Lifesciences Corporation report to view the information.
Incorporation Date:
July 20, 1999
Key Executives
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
12.3%
Purchase this report to view the information.
7.4%
Purchase this report to view the information.
0.7%
Company Performance
Financial values in the chart are available after Enzychem Lifesciences Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
1.76%▲
Total operating revenue
-1.04%▼
Operating Profit/Loss (EBIT)
-72.53%▼
EBITDA
-9.48%▼
Net Profit/Loss for the Period
-134.91%▼
Total Assets
-14.09%▼
Total Equity
-17.03%▼
Operating Profit Margin (ROS)
-13.44%▼
Net Profit Margin
-16.17%▼
Return on Equity (ROE)
-8.85%▼
Debt/Equity
0.11%▲
Quick Ratio
0.7%▲
Cash Ratio
-0.18%▼

Similar companies

Cj Cheiljedang Corporation
 
Kt&G Corporation
Amore Pacific Group
 
Samsung Biologics Co., Ltd.
Green Cross Holdings Corporation
 
Yuhan Corporation
BC World Pharm Co., Ltd.
 
Korean Drug Co.,Ltd.
Icure Pharmaceutical Incorporation
 
CXI Healthcare Technology Group Limited
Mitsubishi Tanabe Pharma Korea Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo